Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleResearch Article

The Synergistic Inhibitory Effect of STI571 in Combination with Arsenic Trioxide (AS2O3) on Multidrug-Resistant Leukemic Cells

Li Chen, Jianmin Wang, Xiaoping Xu, Lei Gao, Xinhong Fei, Jingwei Lou and Zhengxia Huang
Chinese Journal of Clinical Oncology June 2005, 2 (3) 671-674;
Li Chen
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yuhe0628{at}yahoo.com.cn
Jianmin Wang
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoping Xu
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Gao
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinhong Fei
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingwei Lou
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengxia Huang
Department of Hematology, Changhai Hospital of The Second Military Medical University, Shanghai 200433, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1. Comparison of the inhibition by STI571 on the K562-n and K562-n/VCR cells
    Survival rate (%)
    STI571 (μmol/L)K562-nK562-n/VCR
    0.0195.04 ± 7.0096.22 ± 9.72
    0.188.38 ± 4.5794.28 ± 5.23
    118.60 ± 2.0474.52 ± 4.22
    1012.54 ± 1.4433.91 ± 0.17
    1007.34 ± 1.298.15 ± 1.52
    IC500.7043.382
    • View popup
    Table 2. The inhibitory effect of the combined treatment of STI571 and As2O3 on K562-n/VCR cells
    Survival rate of cells (%)
    As2O3 dosage (mol/L, x ± s)
    Groups0.010.1110100IC50Synergistic effect
    As2O392.33 ± 2.5781.66 ± 0.6179.49 ± 1.8716.11 ± 0.2211.75 ± 1.221.879-
    As2O3+STI57165.41 ± 2.1557.80 ± 0.6948.31 ± 2.7511.53 ± 1.0310.70 ± 0.520.15512.12
    • Note: The final concentration of STI571 was 1 μmol/L.

PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 2 (3)
Chinese Journal of Clinical Oncology
Vol. 2, Issue 3
1 Jun 2005
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Synergistic Inhibitory Effect of STI571 in Combination with Arsenic Trioxide (AS2O3) on Multidrug-Resistant Leukemic Cells
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
The Synergistic Inhibitory Effect of STI571 in Combination with Arsenic Trioxide (AS2O3) on Multidrug-Resistant Leukemic Cells
Li Chen, Jianmin Wang, Xiaoping Xu, Lei Gao, Xinhong Fei, Jingwei Lou, Zhengxia Huang
Chinese Journal of Clinical Oncology Jun 2005, 2 (3) 671-674;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Synergistic Inhibitory Effect of STI571 in Combination with Arsenic Trioxide (AS2O3) on Multidrug-Resistant Leukemic Cells
Li Chen, Jianmin Wang, Xiaoping Xu, Lei Gao, Xinhong Fei, Jingwei Lou, Zhengxia Huang
Chinese Journal of Clinical Oncology Jun 2005, 2 (3) 671-674;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • DISCUSSION
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer
  • Pemetrexed Monotherapy and Pemetrexed Plus Platinum Combination Therapy as Non-First-Line Treatments for Advanced Non-Small Cell Lung Cancer
  • Multi-Targeted Therapies in Non-Small Cell Lung Cancer
Show more Research Article

Similar Articles

Keywords

  • STI571
  • arsenic trioxide
  • gene
  • bcr-abl
  • multidrug resistance

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire